These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 15142686)
1. Stopping warfarin therapy is unnecessary for hand surgery. Wallace DL; Latimer MD; Belcher HJ J Hand Surg Br; 2004 Jun; 29(3):203-5. PubMed ID: 15142686 [TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Douketis JD; Johnson JA; Turpie AG Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166 [TBL] [Abstract][Full Text] [Related]
3. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
4. Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin. Tischenko A; Gula LJ; Yee R; Klein GJ; Skanes AC; Krahn AD Am Heart J; 2009 Aug; 158(2):252-6. PubMed ID: 19619702 [TBL] [Abstract][Full Text] [Related]
5. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803 [TBL] [Abstract][Full Text] [Related]
6. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. White HD; Gruber M; Feyzi J; Kaatz S; Tse HF; Husted S; Albers GW Arch Intern Med; 2007 Feb; 167(3):239-45. PubMed ID: 17296878 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology of subtherapeutic anticoagulation in the United States. Rose AJ; Ozonoff A; Grant RW; Henault LE; Hylek EM Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):591-7. PubMed ID: 20031897 [TBL] [Abstract][Full Text] [Related]
8. Risk of thromboembolism with short-term interruption of warfarin therapy. Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197 [TBL] [Abstract][Full Text] [Related]
9. Periprocedural management of anticoagulation in patients on extended warfarin therapy. Jafri SM; Mehta TP Semin Thromb Hemost; 2004 Dec; 30(6):657-64. PubMed ID: 15630672 [TBL] [Abstract][Full Text] [Related]
10. [The application of thrombin generation tests to warfarin anticoagulation monitoring]. Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615 [TBL] [Abstract][Full Text] [Related]
11. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic. Abdelhafiz AH; Wheeldon NM Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009 [TBL] [Abstract][Full Text] [Related]
12. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study. Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA; Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012 [TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Wazni OM; Beheiry S; Fahmy T; Barrett C; Hao S; Patel D; Di Biase L; Martin DO; Kanj M; Arruda M; Cummings J; Schweikert R; Saliba W; Natale A Circulation; 2007 Nov; 116(22):2531-4. PubMed ID: 17998456 [TBL] [Abstract][Full Text] [Related]
14. Elective hand surgery in patients taking warfarin. Smit A; Hooper G J Hand Surg Br; 2004 Jun; 29(3):206-7. PubMed ID: 15142687 [TBL] [Abstract][Full Text] [Related]
15. Delayed discharges due to initiation of warfarin in atrial fibrillation: a prospective audit. Tan ES; Bonnett TJ; Abdelhafiz AH Am J Geriatr Pharmacother; 2007 Sep; 5(3):232-5. PubMed ID: 17996662 [TBL] [Abstract][Full Text] [Related]
16. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy. Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577 [TBL] [Abstract][Full Text] [Related]
17. Perioperative international normalized ratio level is a poor predictor of postoperative bleeding complications in dermatological surgery patients taking warfarin. Blasdale C; Lawrence CM Br J Dermatol; 2008 Mar; 158(3):522-6. PubMed ID: 18241270 [TBL] [Abstract][Full Text] [Related]
18. In-patient international normalized ratio self-testing instruction after mechanical heart valve implantation. Thompson JL; Sundt TM; Sarano ME; Santrach PJ; Schaff HV Ann Thorac Surg; 2008 Jun; 85(6):2046-50. PubMed ID: 18498817 [TBL] [Abstract][Full Text] [Related]
20. Comparison of physician- and pharmacist-managed warfarin sodium treatment in open heart surgery patients. Tschol N; Lai DK; Tilley JA; Wong H; Brown GR Can J Cardiol; 2003 Nov; 19(12):1413-7. PubMed ID: 14631476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]